14158 Results (Page 108 of 567)
All Market Research Reports
Egypt Antifungal Drugs Market Analysis
Egypt Antifungal Drugs Market is at around $0.04 Bn in 2023 and is projected to reach $0.06 Bn in 2030, exhibiting a CAGR of 5.3% during the forecast period. The market is driven by rising rates of fungal infections, the growth of the pharmaceutical industry, and government initiatives and policies. The market is dominated by key players like GlaxoSmithKline plc, Pfizer Inc., Merck & Co., Novartis AG, Abbott Laboratories, Astellas Pharma Inc., Sanofi S.A., Bayer AG, Glenmark Pharmaceuticals Limited, and Gilead Sciences Inc.
Vietnam Antifungal Drugs Market Analysis
Vietnam Antifungal Drugs Market is at around $0.07 Bn in 2023 and is projected to reach $0.01 Bn in 2030, exhibiting a CAGR of 4.03% during the forecast period. The market is expanding due to factors like changing lifestyles and urbanization, improvements in healthcare infrastructure, and increased public awareness of fungal infections. The market is dominated by key players like Sanofi-Aventis, Pfizer Inc., Merck & Co., Novartis AG, Abbott Laboratories, Astellas Pharma Inc., GlaxoSmithKline plc, Bayer AG, Glenmark Pharmaceuticals Limited, and Gilead Sciences Inc.
Singapore Antifungal Drugs Market Analysis
Singapore Antifungal Drugs Market is at around $0.019 Bn in 2023 and is projected to reach $0.026 Bn in 2030, exhibiting a CAGR of 4.4% during the forecast period. The market is expanding due to rising awareness and education, advancements in healthcare infrastructure, and an increase in the incidence of fungal infections. The market is dominated by key players like Pfizer Inc., Merck & Co., Novartis AG, Abbott Laboratories, Astellas Pharma Inc., GlaxoSmithKline plc, Bayer AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
Philippines Antifungal Drugs Market Analysis
Philippines Antifungal Drugs Market is at around $0.03 Bn in 2023 and is projected to reach $0.4 Bn in 2030, exhibiting a CAGR of 4.3% during the forecast period. The market is driven by factors such as aging populations and immunocompromised patients, growing awareness and education, and advancements in healthcare infrastructure. The market is dominated by key players like United Laboratories Inc., Merck & Co., Pfizer Inc., Novartis AG, Abbott Laboratories, Astellas Pharma Inc., GlaxoSmithKline plc, Bayer AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
Japan Antifungal Drugs Market Analysis
Japan Antifungal Drugs Market is at around $0.98 Bn in 2023 and is projected to reach $1.33 Bn in 2030, exhibiting a CAGR of 4.3% during the forecast period. The market is expanding due to rising healthcare costs, the prevalence of risk factors, and technological advancements. The market is dominated by key players like Merck & Co., Pfizer Inc., Novartis AG, Abbott Laboratories, Astellas Pharma Inc., GlaxoSmithKline plc, Bayer AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
Malaysia Antifungal Drugs Market Analysis
Malaysia Antifungal Drugs Market is at around $0.025 Bn in 2023 and is projected to reach $0.033 Bn in 2030, exhibiting a CAGR of 4% during the forecast period. The market is being driven by rising rates of fungal infections, rising healthcare costs, and improvements in healthcare infrastructure. The market is dominated by key players like Pharmaniaga Bhd., Duipharma Biotech Bhd., Pfizer Inc., Novartis AG, Merck & Co., Inc., Abbott Laboratories, Astellas Pharma Inc., GlaxoSmithKline plc, Bayer AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
Indonesia Antifungal Drugs Market Analysis
Indonesia Antifungal Drugs Market is at around $0.09 Bn in 2023 and is projected to reach $0.12 Bn in 2030, exhibiting a CAGR of 3.8% during the forecast period. The industry is driven by rising healthcare spending, rising awareness and education, and technological advancements. The market is dominated by key players like Pfizer Inc., Novartis AG, Merck & Co., Inc., Abbott Laboratories, Astellas Pharma Inc., GlaxoSmithKline plc, Bayer AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
China Antifungal Drugs Market Analysis
China Antifungal Drugs Market is at around $1.3 Bn in 2023 and is projected to reach $1.8 Bn in 2030, exhibiting a CAGR of 5.3% during the forecast period. The factors propelling the market's expansion include government initiatives and healthcare policies, enhanced diagnosis and awareness, epidemiological shifts, and antifungal resistance. The market is dominated by key players like Novartis AG, Merck & Co., Inc., Pfizer Inc., Abbott Laboratories, Astellas Pharma Inc., GlaxoSmithKline plc, Bayer AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
UK Antifungal Drugs Market Analysis
UK Antifungal Drugs Market is at around $0.4 Bn in 2023 and is projected to reach $0.5 Bn in 2030, exhibiting a CAGR of 1.8% during the forecast period. The rise in the market is being driven by the rising prevalence of fungal infections, improvements in healthcare infrastructure, and technological advancements in drug development. The market is dominated by key players like Merck & Co., Inc., Pfizer Inc., Abbott Laboratories, Astellas Pharma Inc., GlaxoSmithKline plc, Bayer AG, Novartis AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
Spain Antifungal Drugs Market Analysis
Spain Antifungal Drugs Market is at around $0.31 Bn in 2023 and is projected to reach $0.4 Bn in 2030, exhibiting a CAGR of 2.8% during the forecast period. The industry is being driven by the aging population, rising awareness and education, and medical technology advancements in the field. The market is dominated by key players like Merck & Co., Inc., Pfizer Inc., Abbott Laboratories, Astellas Pharma Inc., GlaxoSmithKline plc, Bayer AG, Novartis AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
Germany Antifungal Drugs Market Analysis
Germany Antifungal Drugs Market is at around $0.57 Bn in 2023 and is projected to reach $0.67 Bn in 2030, exhibiting a CAGR of 2% during the forecast period. Factors like growing antifungal resistance, increasing R&D activities, and increasing incidence of fungal infections are driving the market. The market is dominated by key players like Pfizer Inc., Abbott Laboratories, Merck & Co., Inc., Astellas Pharma Inc., GlaxoSmithKline plc, Bayer AG, Novartis AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
France Antifungal Drugs Market Analysis
France Antifungal Drugs Market is at around $0.43 Bn in 2023 and is projected to reach $0.53 Bn in 2030, exhibiting a CAGR of 2.8% during the forecast period. The market is expanding due to factors such as rising awareness and education, advancements in healthcare infrastructure, and an increase in the incidence of fungal infections. The market is dominated by key players like Pfizer Inc., Abbott Laboratories, Merck & Co., Inc., Astellas Pharma Inc., GlaxoSmithKline plc, Bayer AG, Novartis AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
Mexico Antifungal Drugs Market Analysis
Mexico Antifungal Drugs Market is at around $0.2 Bn in 2023 and is projected to reach $0.3 Bn in 2030, exhibiting a CAGR of 4.05% during the forecast period. The market is being driven by innovations and developments in drugs, awareness, and education about fungal infections, and healthcare infrastructure. The market is dominated by key players like Abbott Laboratories, Merck & Co., Inc., Astellas Pharma Inc., Pfizer Inc., GlaxoSmithKline plc, Bayer AG, Novartis AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
Brazil Antifungal Drugs Market Analysis
Brazil Antifungal Drugs Market is at around $0.4 Bn in 2023 and is projected to reach $0.55 Bn in 2030, exhibiting a CAGR of 4.8% during the forecast period. The market is expanding as a result of rising fungal infections, improvements in healthcare infrastructure, and the development of antifungal drugs. The market is dominated by key players like EMS Farmaceutia S.A., Abbott Laboratories, Merck & Co., Inc., Astellas Pharma Inc., Pfizer Inc., GlaxoSmithKline plc, Bayer AG, Novartis AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
UAE Antifungal Drugs Market Analysis
UAE Antifungal Drugs Market is at around $0.07 Bn in 2023 and is projected to reach $0.1 Bn in 2030, exhibiting a CAGR of 4.8% during the forecast period. The market is expanding due to factors such as the prevalence of fungal infections, improvements in healthcare infrastructure, and technological advancements in drug development. The market is dominated by key players like Neopharma, Abbott Laboratories, Merck & Co., Inc., Astellas Pharma Inc., Pfizer Inc., GlaxoSmithKline plc, Bayer AG, Novartis AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
Saudi Arabia Antifungal Drugs Market Analysis
Saudi Arabia Antifungal Drugs Market is at around $0.27 Bn in 2023 and is projected to reach $0.39 Bn in 2030, exhibiting a CAGR of 5.3% during the forecast period. Government initiatives, healthcare infrastructure, and awareness and education regarding fungal diseases are the factors propelling the market's growth. The market is dominated by key players like Abbott Laboratories, Merck & Co., Inc., Astellas Pharma Inc., Pfizer Inc., GlaxoSmithKline plc, Bayer AG, Novartis AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
US Antifungal Drugs Market Analysis
US Antifungal Drugs Market is at around $6.64 Bn in 2023 and is projected to reach $7.52 Bn in 2030, exhibiting a CAGR of 1.8% during the forecast period. The market is being driven by rising rates of fungal infections, improvements in drug development, and increase in antifungal resistance. The market is dominated by key players like Pfizer Inc., Merck & Co., Inc., Astellas Pharma Inc., Abbott Laboratories, GlaxoSmithKline plc, Bayer AG, Novartis AG, Glenmark Pharmaceuticals Limited, Sanofi, and Enzon Pharmaceuticals, Inc.
Canada Antifungal Drugs Market Analysis
Canada Antifungal Drugs Market is at around $1.3 Bn in 2023 and is projected to reach $1.6 Bn in 2030, exhibiting a CAGR of 3.8% during the forecast period. The market is growing due to the prevalence of fungal infections, consumer awareness and education, and partnerships and collaborations. The market is dominated by key players like Apotex Inc., Paladin Labs Inc., Abbott Laboratories, Merck & Co., Inc., Astellas Pharma Inc., Pfizer Inc., GlaxoSmithKline plc, Bayer AG, Novartis AG, and Glenmark Pharmaceuticals Limited.
Vietnam ePharmacy Market Analysis
This report presents a strategic analysis of the Vietnam ePharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam ePharmacy Market, offering unmatched value, accuracy, and expert insights.
Vietnam Vitamin and Minerals Market Analysis
This report presents a strategic analysis of the Vietnam Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam Vitamin and Minerals Market, offering unmatched value, accuracy, and expert insights.
Vietnam Patient Support Programs (PSP) Market Analysis
This report presents a strategic analysis of the Vietnam Patient Support Programs (PSP) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam Patient Support Programs (PSP) Market, offering unmatched value, accuracy, and expert insights.
Vietnam Orphan Diseases Drugs Market Analysis
This report presents a strategic analysis of the Vietnam Orphan Diseases Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam Orphan Diseases Drugs Market, offering unmatched value, accuracy, and expert insights.
Vietnam Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Vietnam Lung Cancer Therapeutics Market will reach a value of $283 Mn from $149 Mn in 2022, growing at a CAGR of 8.3% during 2022-30. The Lung Cancer Therapeutics Market in Vietnam is dominated by a few domestic pharmaceutical companies such as Hau Giang Pharmaceutical, Traphaco, and Vietnam Pharmaceutical. The Lung Cancer Therapeutics Market in Vietnam is segmented into different types of cancer and different therapy types. Some of the major factors affecting the Vietnam lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies, and the presence of highly efficient drugs.
Vietnam Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Vietnam liver cancer therapeutics market will reach a value of $54.4 Mn from $14.65 Mn in 2022, growing at a CAGR of 17.8% during 2022-30. Liver cancer therapeutics in Vietnam are dominated by a few domestic pharmaceutical companies such as OPC Pharmaceutical, Vimedimex Medi-Pharma, and Hau Giang Pharmaceutical. The liver cancer therapeutics market in Vietnam is segmented into different types of cancer and different therapy types. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Vietnam Insulin Market Analysis
This report presents a strategic analysis of the Vietnam Insulin Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Vietnam Insulin Market, offering unmatched value, accuracy, and expert insights.
